Finance Watch: More Than $4.2bn Raised Across Four New VC Funds
Triveni, Nusano Garnered $115m Each For Clinical Assets
Private Company Edition: ARCH raised more than $3bn for its eighth fund, Frazier added $630m to its public fund that also can back crossover rounds, DCVC’s third biotech fund totaled $400m and Asabys raised €180m ($200m) for its second fund. Also, Aktis closed a $175m series B round.
